In this process, LINC00844 promotes the expression of N-myc downstream regulatory gene 1 (NDRG1), and NDRG1 acts as an AR repressor to inhibit AR expression, and the metastasis and differentiation of prostate cancer cells are also inhibited after the AR signaling pathway is suppressed. Here, NDRG1 is linked to prostate cancer.